中国生物科技服务(08037)公布中期业绩公司拥有人应占亏损3200.6万港元同比收窄59.95%

智通财经08-27

智通财经APP讯，中国生物科技服务(08037)公布2025年中期业绩，收入3887.2万港元，同比增长19.79%;公司拥有人应占亏损3200.6万港元，同比收窄59.95%;每股亏损0.033港元。公告称，亏损改善的主要原因是公司成功实施成本控制措施，导致毛利率上升及行政开支减少，以及就2024年发生的暴雨对海南建筑工地造成的损害作出保险申索而获得赔偿收入约1370万港元。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2562172813?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-27 23:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562172813","market":"fut","top_or_hot":-1,"title":"中国生物科技服务(08037)公布中期业绩 公司拥有人应占亏损3200.6万港元 同比收窄59.95%","media":"智通财经","content":"<div>\n<p>智通财经APP讯，中国生物科技服务(08037)公布2025年中期业绩，收入3887.2万港元，同比增长19.79%;公司拥有人应占亏损3200.6万港元，同比收窄59.95%;每股亏损0.033港元。公告称，亏损改善的主要原因是公司成功实施成本控制措施，导致毛利率上升及行政开支减少，以及就2024年发生的暴雨对海南建筑工地造成的损害作出保险申索而获得赔偿收入约1370万港元。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1336774.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国生物科技服务(08037)公布中期业绩 公司拥有人应占亏损3200.6万港元 同比收窄59.95%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国生物科技服务(08037)公布中期业绩 公司拥有人应占亏损3200.6万港元 同比收窄59.95%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-27 23:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1336774.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，中国生物科技服务(08037)公布2025年中期业绩，收入3887.2万港元，同比增长19.79%;公司拥有人应占亏损3200.6万港元，同比收窄59.95%;每股亏损0.033港元。公告称，亏损改善的主要原因是公司成功实施成本控制措施，导致毛利率上升及行政开支减少，以及就2024年发生的暴雨对海南建筑工地造成的损害作出保险申索而获得赔偿收入约1370万港元。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1336774.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1511","symbol_name":"疑似财技股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1336774.html","article_id":"2562172813","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562172813","pubTimestamp":1756307420,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，中国生物科技服务(08037)公布2025年中期业绩，收入3887.2万港元，同比增长19.79%;公司拥有人应占亏损3200.6万港元，同比收窄59.95%;每股亏损0.033港元。公告称，亏损改善的主要原因是公司成功实施成本控制措施，导致毛利率上升及行政开支减少，以及就2024年发生的暴雨对海南建筑工地造成的损害作出保险申索而获得赔偿收入约1370万港元。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1511":"疑似财技股","08037":"中国生物科技服务","BK1219":"保健护理服务"},"translate_title":"China Biotechnology Services (08037) announced interim results, and the loss attributable to the company's owners was HK $32.006 million, narrowing by 59.95% year-on-year.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"智通财经APP讯，中国生物科技服务(08037)公布2025年中期业绩，收入3887.2万港元，同比增长19.79%;公司拥有人应占亏损3200.6万港元，同比收窄59.95%;每股亏损0.033港元。公告称，亏损改善的主要原因是公司成功实施成本控制措施，导致毛利率上升及行政开支减少，以及就2024年发生的暴雨对海南建筑工地造成的损害作出保险申索而获得赔偿收入约1370万港元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2562172813","isCrawlerRequest":true}

中国生物科技服务(08037)公布中期业绩 公司拥有人应占亏损3200.6万港元 同比收窄59.95%

精彩评论

中国生物科技服务(08037)公布中期业绩公司拥有人应占亏损3200.6万港元同比收窄59.95%